You are here : ERS > E-Resources > Publications > ERJ > Archive > European Respiratory Journal (ERJ) - Archive > 2011 > February > Prognostic value of procalcitonin in community-acquired pneumonia

 European Respiratory Journal (ERJ) - Archive

February (Issue 2 Volume 37)
384
Prognostic value of procalcitonin in community-acquired pneumonia
Place a comment or grade
Schuetz P., Suter-Widmer I., Chaudri A., Christ-Crain M., Zimmerli W., Mueller B.
Eur Respir J 2011; 37: 384		Full textPDF-fileAbstract

Abstract
The prognostic value of procalcitonin (PCT) levels to predict mortality and other adverse events in community-acquired pneumonia (CAP) remains undefined. We assessed the performance of PCT overall, stratified into four predefined procalcitonin tiers (<0. 1, 0. 1–0. 25, >0. 25–0. 5, >0. 5 ?g•L?1) and stratified by Pneumonia Severity Index (PSI) and CURB-65 (confusion, urea >7 mmol•L?1, respiratory frequency ?30 breaths•min?1, systolic blood pressure <90 mmHg or diastolic blood pressure ?60 mmHg,... [View all]
WHAT YOU CAN FIND HERE  
Full text article Full text journal article
PDF file PDF journal article
Abstract Journal article abstract
                   
ERS